-
1
-
-
0023854176
-
Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
-
LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
-
(1988)
J Rheumatol
, vol.15
, pp. 202-205
-
-
LeRoy, E.C.1
Black, C.2
Fleischmajer, R.3
-
2
-
-
0036064618
-
Scleroderma and Smads: Dysfunctional Smad family dynamics culminating in fibrosis
-
Varga J. Scleroderma and Smads: Dysfunctional Smad family dynamics culminating in fibrosis. Arthritis Rheum 2002;46:1703-13.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 1703-1713
-
-
Varga, J.1
-
3
-
-
0024242956
-
Visceral improvement following combined plasmapheresis and immunosuppressive drug therapy in progressive systemic sclerosis
-
Akesson A, Wollhelm FA, Thysell H et al. Visceral improvement following combined plasmapheresis and immunosuppressive drug therapy in progressive systemic sclerosis. Scand J Rheumatol 1988;17:313-23.
-
(1988)
Scand J Rheumatol
, vol.17
, pp. 313-323
-
-
Akesson, A.1
Wollhelm, F.A.2
Thysell, H.3
-
4
-
-
0035678255
-
Improvement in skin thickening in systemic sclerosis associated with improved survival
-
Steen VD, Medsger TA Jr. Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 2001;14:2828-35.
-
(2001)
Arthritis Rheum
, vol.14
, pp. 2828-2835
-
-
Steen, V.D.1
Medsger Jr., T.A.2
-
5
-
-
33745227399
-
Cyclophosphamide versus placebo in scleroderma lung disease
-
Tashkin DP, Elashoff R, Clements PJ et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006;354:2655-66.
-
(2006)
N Engl J Med
, vol.354
, pp. 2655-2666
-
-
Tashkin, D.P.1
Elashoff, R.2
Clements, P.J.3
-
6
-
-
33846250366
-
Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192
-
Denton CP, Merkel PA, Furst DE et al. Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192. Arthritis Rheum 2007;56:323-33.
-
(2007)
Arthritis Rheum
, vol.56
, pp. 323-333
-
-
Denton, C.P.1
Merkel, P.A.2
Furst, D.E.3
-
7
-
-
0018345789
-
Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma
-
Rodnan GP, Lipinski E, Luksick J. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 1979;22:130-40.
-
(1979)
Arthritis Rheum
, vol.22
, pp. 130-140
-
-
Rodnan, G.P.1
Lipinski, E.2
Luksick, J.3
-
8
-
-
0031771507
-
Mortality and causes of death in a Swedish series of systemic sclerosis patients
-
Hesselstrand R, Scheja A, Åkesson, A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998;57:682-6.
-
(1998)
Ann Rheum Dis
, vol.57
, pp. 682-686
-
-
Hesselstrand, R.1
Scheja, A.2
Åkesson, A.3
-
9
-
-
0026316776
-
Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved skin
-
Claman HN, Giomo RC, Seibold JR. Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved skin". Arthritis Rheum 1991;34:1495-501.
-
(1991)
Arthritis Rheum
, vol.34
, pp. 1495-1501
-
-
Claman, H.N.1
Giomo, R.C.2
Seibold, J.R.3
-
10
-
-
0029114881
-
Ultrasound measurement of skin thickness in systemic sclerosis
-
Ihn H, Shimozuma M, Fujimoto M et al. Ultrasound measurement of skin thickness in systemic sclerosis. Br J Rheumatol 1995;34:535-8.
-
(1995)
Br J Rheumatol
, vol.34
, pp. 535-538
-
-
Ihn, H.1
Shimozuma, M.2
Fujimoto, M.3
-
11
-
-
33747874395
-
Durometry for the assessment of skin disease in systemic sclerosis
-
Kissin EY, Schiller AM, Gelbard RB et al. Durometry for the assessment of skin disease in systemic sclerosis. Arthritis Rheum 2006;55:603-9.
-
(2006)
Arthritis Rheum
, vol.55
, pp. 603-609
-
-
Kissin, E.Y.1
Schiller, A.M.2
Gelbard, R.B.3
-
12
-
-
0036558833
-
The association between changes in skin echogenicity and the fibroblast production of biglycan and versican in systemic sclerosis
-
Hesselstrand R, Westergren-Thorsson G, Scheja A, Wildt M, Akesson A. The association between changes in skin echogenicity and the fibroblast production of biglycan and versican in systemic sclerosis. Clin Exp Rheumatol 2002;20:301-8.
-
(2002)
Clin Exp Rheumatol
, vol.20
, pp. 301-308
-
-
Hesselstrand, R.1
Westergren-Thorsson, G.2
Scheja, A.3
Wildt, M.4
Akesson, A.5
-
13
-
-
3042781369
-
Longitudinal development of skin involvement and reliability of high frequency ultrasound in systemic sclerosis
-
Akesson A, Hesselstrand R, Scheja A, Wildt M. Longitudinal development of skin involvement and reliability of high frequency ultrasound in systemic sclerosis. Ann Rheum Dis 2004;63:791-6.
-
(2004)
Ann Rheum Dis
, vol.63
, pp. 791-796
-
-
Akesson, A.1
Hesselstrand, R.2
Scheja, A.3
Wildt, M.4
-
14
-
-
0345099468
-
Seventeen-point dermal ultrasound scoring system - a reliable measure of skin thickness in patients with systemic sclerosis
-
Moore TL, McManus B, Anderson ME, Herrick AL. Seventeen-point dermal ultrasound scoring system - a reliable measure of skin thickness in patients with systemic sclerosis. Rheumatology 2003;42:1559-63.
-
(2003)
Rheumatology
, vol.42
, pp. 1559-1563
-
-
Moore, T.L.1
McManus, B.2
Anderson, M.E.3
Herrick, A.L.4
-
15
-
-
0018887574
-
Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee
-
Masi AT, Medsger TA Jr et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
-
(1980)
Arthritis Rheum
, vol.23
, pp. 581-590
-
-
Masi, A.T.1
Medsger Jr, T.A.2
-
16
-
-
0029048089
-
Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis
-
Clements P, Lachenbruch P, Seibold J et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
-
(1995)
J Rheumatol
, vol.22
, pp. 1281-1285
-
-
Clements, P.1
Lachenbruch, P.2
Seibold, J.3
-
17
-
-
0030950780
-
Comparison of high frequency (20 MHz) ultrasound and palpation for the assessment of skin involvement in systemic sclerosis (scleroderma)
-
Scheja A, Akesson A. Comparison of high frequency (20 MHz) ultrasound and palpation for the assessment of skin involvement in systemic sclerosis (scleroderma). Clin Exp Rheumatol 1997;15:283-8.
-
(1997)
Clin Exp Rheumatol
, vol.15
, pp. 283-288
-
-
Scheja, A.1
Akesson, A.2
|